Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. (Q37398972)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 July 2016
edit
Language Label Description Also known as
English
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.
scientific article published on 26 July 2016

    Statements

    Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit